← Leaderboards
Curtis Jones
Retham Technologies, Inc.
$3,128,069
Attributed
$3,128,069
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,128,069 · 2
By mechanism
R44$2,903,398 · 1
R43$224,671 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Legal Patent”
- Bala Raja · Luminostics, Inc.$28,624,460
- Nikej Shah · Nirsum Laboratories, Inc.$12,588,496
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,485,488
- Laurie Lucas · Four Points Technology, Llc$9,526,424
- Matthew Golden · Maphabit, Inc.$8,248,782
- Ashkan Vaziri · Biosensics, Llc$7,399,204
Research focus
Legal PatentPathogenicityHeparin-Induced ThrombocytopeniaLaboratoriesHemorrhageLimb StructureEnzyme-Linked Immunosorbent AssayHeparinHospital LaboratoriesDiagnostic AssayFamilyCoupledAntibodiesLifeBindingDetectionAnticoagulantsComplicationDiagnosisDiagnostic TestsBlood PlateletsClinically SignificantComplexPatient-Focused Outcomes
Grant awards (5)
An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-inducedThrombocytopenia$1,154,002
R44 · FY2025 · HL · contact PI
An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-induced Thrombocytopenia$49,399
R44 · FY2024 · HL · contact PI
An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-induced Thrombocytopenia$1,220,267
R44 · FY2023 · HL · contact PI
An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-induced Thrombocytopenia$479,730
R44 · FY2022 · HL · contact PI
An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-induced Thrombocytopenia$224,671
R43 · FY2019 · HL · contact PI